Sentences with phrase «availability of program in»

An implementation manual is available and contains useful information and assessments designed to assist in recruiting parents and advertising availability of program in the community.

Start with Code.org, a nonprofit seeking to expand the availability of programming in schools and participation of underrepresented students of color and women.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Factors taken into account when assigning this rating include the ease of enrolling in the program; the fees, if any, of investing through the DRIP; the availability of special services, such as IRAs and automatic investment services; and the frequency of purchases with optional cash investments.

In addition, the Canada Savings Bond program is costly to administer and out dated given the availability of private sector savings instruments.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

In addition, several of the major hotel programs are featured, and transfers from this program are virtually instantaneous, allowing you to book airline tickets or award nights at hotels that you found before the availability disappears.

«Mortgage credit availability increased for the third consecutive month in November, driven by increased availability of conventional low down payment and streamlined refinance loan programs,» said Lynn Fisher, MBA's vice president of research and economics.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

(Howard Clinebell, Basic Types of Pastoral Counseling, pp. 189 - 205, 222 - 43; William Glasser, Reality Therapy (New York: Harper, 1965) Perry London, The Modes and Morale of Psychotherapy [New York: Holt, Rinehart, and Winston, 1964]-RRB- Any program of individual and small - group counseling with the poor should attempt to minimize red tape, needless professionalization, and other types of structural frustrations often accompanying more standard services — frustrations such as complex and frightening diagnostic interviews, excessive use of referrals, and delays in the availability of the sought - for service.

And unless the very availability of modern contraceptives by itself stimulates a revolution in attitudes toward family size — as over a quarter of a century of family planning efforts have failed to do in Nepal, and three decades of programs have not done in rural Pakistan — the demographic impact of family planning would be a discrete and self - extinguishing adjustment, as the previously «unmet demand» of motivated users is progressively satisfied.

Our national produce program is the foodservice industry's first comprehensive, national farm to fork program specifically designed with two main goals: to create and commit to continuous sustainable improvements at each touch point in the produce supply chain and to ensure the availability and safety of local produce for operators in all segments of the foodservice and retail markets.

One of the biggest dairy - related stories to break this month was the announcement that as part of their commitment to increase the availability of healthy, American - made food products in schools, the USDA is expanding its pilot program for Greek - style yogurt for the National School Lunch Program in SY 201program for Greek - style yogurt for the National School Lunch Program in SY 201Program in SY 2014 - 15.

We eradicate stigma by increasing the availability and accessibility of mental health care worldwide by: treating patients, training professionals, including psychologists, therapists, OBGYNs, pediatricians, nurses, and midwives, providing public programs, including new parent groups, breastfeeding clinics, and adolescent services, funding research, providing curated content online, and advocating in public and private sectors.

While every effort is made to ensure the accuracy of information in this listing, it is recommended that you contact these programs to check dates, availability, and to request registration information.

In spring 2010, the Health Resources and Services Administration and the Administration for Children announced the availability of funds for the Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Program.39 The program emphasizes and supports successful implementation of high - quality home visiting programs that have demonstrated evidence of effectiveness as defined in the legislatioIn spring 2010, the Health Resources and Services Administration and the Administration for Children announced the availability of funds for the Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Program.39 The program emphasizes and supports successful implementation of high - quality home visiting programs that have demonstrated evidence of effectiveness as defined in the legisProgram.39 The program emphasizes and supports successful implementation of high - quality home visiting programs that have demonstrated evidence of effectiveness as defined in the legisprogram emphasizes and supports successful implementation of high - quality home visiting programs that have demonstrated evidence of effectiveness as defined in the legislatioin the legislation.

In this role, she is responsible for leading the efforts to improve public policies to end hunger, reduce poverty, promote nutrition and increase the availability of healthy affordable food in low - income areas; maximize participation in all federal nutrition programs (SNAP, school meals, early childhood nutrition, WIC, and summer meals); and educate the public about both the stark reality of hunger's existence in the nation's capital and the real opportunities for effective solutionIn this role, she is responsible for leading the efforts to improve public policies to end hunger, reduce poverty, promote nutrition and increase the availability of healthy affordable food in low - income areas; maximize participation in all federal nutrition programs (SNAP, school meals, early childhood nutrition, WIC, and summer meals); and educate the public about both the stark reality of hunger's existence in the nation's capital and the real opportunities for effective solutionin low - income areas; maximize participation in all federal nutrition programs (SNAP, school meals, early childhood nutrition, WIC, and summer meals); and educate the public about both the stark reality of hunger's existence in the nation's capital and the real opportunities for effective solutionin all federal nutrition programs (SNAP, school meals, early childhood nutrition, WIC, and summer meals); and educate the public about both the stark reality of hunger's existence in the nation's capital and the real opportunities for effective solutionin the nation's capital and the real opportunities for effective solutions.

Most stuck to the well - known and trusted recipe, found in Dr. L. Emmett Holt's perennially popular childcare manual, Care and Feeding of Infants, of cow's milk diluted with water and supplemented with sugar.41 Still, the increasing availability and promotion of such products, along with the rise in safer, cleaner cow's milk thanks to certification programs and pasteurization, contributed to a growth in the number of women who bottle fed their infants.

Lastly, it is essential that decision - makers reach out to vulnerable families during the preschool years, as these families are the hardest to involve in parenting programs (obstacles due to language, location, and / or hours of availability).

Effective food policy actions are part of a comprehensive approach to improving nutrition environments, defined as those factors that influence food access.1 Improvements in the nutritional quality of all foods and beverages served and sold in schools have been recommended to protect the nutritional health of children, especially children who live in low - resource communities.2 As legislated by the US Congress, the 2010 Healthy Hunger - Free Kids Act (HHFKA) updated the meal patterns and nutrition standards for the National School Lunch Program and the School Breakfast Program to align with the 2010 Dietary Guidelines for Americans.3 The revised standards, which took effect at the beginning of the 2012 - 2013 school year, increased the availability of whole grains, vegetables, and fruits and specified weekly requirements for beans / peas as well as dark green, red / orange, starchy, and other vegetables.

While it would be awesome to limit the availability of snack bar items from a health perspective (as I argued in a school newspaper article my junior year), doing so would probably be financial suicide for the lunch program, and I absolutely agree with you that they would probably lose about the amount of money that they now are by opting out of the NSLP.

The LAC coincides with National School Breakfast Week (March 7 - 11), a program launched in 1989 to raise awareness about the availability of the School Breakfast Program (SBP) to all chprogram launched in 1989 to raise awareness about the availability of the School Breakfast Program (SBP) to all chProgram (SBP) to all children.

You can search this by Congressional and Legislative districts to understand depth of the program in each district and see the availability of tutor / mentor programs.

Or, they suggest ways you might «connect» with this person in meatspace, being careful in the process to say «Please contact and interact with [name] in ways that are peaceful, non-violent, and in no way cause any impairment to the integrity or availability of [company] data, programs, systems, or information.»

«The Mobile and Manufactured Home Replacement Program helps to address a critical shortfall in the availability of safe, affordable housing for low - income families in rural areas of New York State,» said Assemblyman Steven Cymbrowitz, Chair of the Assembly's Housing Committee.

The pilot program will provide extra availability of services to these cients in need, while also modernizing ECDSS to the level of other County units that have hours - beyond - usual, such as the Department of Motor Vehicles.

Other parts of the anti-obesity proposal include: ensuring new schools are built with dedicated activity space; creating a program to send doctors into homes to develop preventive programs for children with asthma; increasing the availability of free food programs for children; and doubling the number of school - based health centers in the city to 250.

Senate Housing Committee Chairperson Senator Betty Little said: «The Mobile and Manufactured Home Replacement Program will help address a shortfall in the availability of safe, affordable housing for low - income families in the North Country and other rural areas of New York State.

At 12:45 p.m., DiNapoli visits serval local programs and businesses in Schenectady with Assemblymen Angelo Santabarbara and Phil Steck and Mayor Gary McCarthy and then holds a media availability in front of the Phyllis Bornt Library, 948 State St., Schenectady.

The group would monitor the extent and complications of opioid addiction; spread awareness of symptoms and aftereffects through seminars and workshops; monitor and assess the state of and improvements in treatment modalities; interface with manufacturers, retailers, and physicians offering products to treat pain; pressure the medical community to reduce availability of addictive analgesics and advocate for nonaddictive substitutes, and maintain an interface between treatment programs and similar programs targeted at youth, health care, aging, and housing.

Schumer called the bill a critical first step in the fight against heroin and opioids, expanding the availability of naloxone — also known as narcan — to law enforcement and first responders, improving prescription drug monitoring programs, shifting resources to identifying and treating incarcerated people suffering from addiction, and prohibiting the Department of Education from questioning students about prior drug convictions on financial aid forms.

Beyond the payroll tax and charitable donation programs, Cuomo offered up ideas to reduce traffic congestion in New York City, expand availability of flu vaccines for children, impose restrictions on sex offenders, provide funding for an early voting program, ban synthetic marijuana sales and target physicians who engage in medical misconduct.

The Erie County Department of Environment and Planning is announcing the availability of $ 350,000 in federal funding from the HOME Investment Partnership Program (HOME).

«Countries using these measures should instead increase the availability of proven opioid - agonist therapies, such as methadone, and ensure there is adequate access to voluntary treatment programs in community settings and facilitate people with opioid addiction to seek treatment.»

«Because resource availability varies widely, both among and within countries, we need to adjust strategies to improve access to HPV vaccination everywhere,» said Silvia de Sanjosé, MD, PhD, co-chair of the Expert Panel that developed the guideline and head of the Cancer Epidemiology Research Program at Institut Català d'Oncologia in Barcelona, Spain.

According to a 2013 study of California farmers, factors like exposure to extreme weather events and perceived changes in water availability made farmers more likely to believe in climate change, while negative experiences with environmental policies can make farmers less likely to believe that climate change is occurring, said Meredith Niles, a postdoctoral research fellow at Harvard's Sustainability Science Program and lead author of the study.

Schuchat stressed that HHS Secretary Kathleen Sebelius «has announced that we are planning for a voluntary vaccination program in the fall, assuming availability of appropriate vaccine and that the virus hasn't changed so substantially that a vaccine wouldn't work.»

The question of how this works in detail, and what factors influence the availability of molecular hydrogen (or not), will be guiding a Large Observation Program with ALMA that Walter and his colleagues have been awarded, in part based on their present results.

«In the Southwest, water availability for irrigation is already a concern,» says first author Elodie Blanc, a research scientist at MIT's Joint Program on the Science and Policy of Global Change.

In addition, a policy that was found to impact the availability of behavioral health treatment services in health centers was whether state Medicaid programs — the major source of insurance revenue for health centers — pay separately for behavioral services when they are rendered on the same day that medical care is provided, a policy known as same - day billinIn addition, a policy that was found to impact the availability of behavioral health treatment services in health centers was whether state Medicaid programs — the major source of insurance revenue for health centers — pay separately for behavioral services when they are rendered on the same day that medical care is provided, a policy known as same - day billinin health centers was whether state Medicaid programs — the major source of insurance revenue for health centers — pay separately for behavioral services when they are rendered on the same day that medical care is provided, a policy known as same - day billing.

Such programs, best undertaken in an adaptive management framework, include, but are not limited to, reducing fire risk; managing forest diseases; improving forest establishment; increasing forest carbon storage; improving water availability and soil quality; improving forest diversity, structure, and resilience; and increasing genetic and phenotypic diversity of forests.

1,800 Master's programs are offered in English, however, please note that availability of English - taught programs may depend on the subject area.

Buying products that are verified by our program is the best way to support the sustained availability of non-GMO choices in North America.

The Corporation for National and Community Service in the Jan. 19 Federal Register announced the availability of guidelines for service programs seeking grants.

Almost one - quarter of school districts nationwide and nine states have invested millions of dollars in «one - to - one» laptop programs, hoping the availability of a computer for every student will improve achievement and other skills.

The limited availability of the Perkins program is partly what prompted Congress to create the Teacher Loan Forgiveness program for the more widely available Stafford Loans in 1998.

While more data is required to inform future policies and practice, the evidence we have highlights a disconnection between how early career teachers and school principals perceive the availability of school - based professional induction programs in the crucial first two years of teaching.

In practice, however, determining LRE can be heavily influenced by other factors, such as the availability of existing programs and qualified staff.

Mark has suggested that mobile learning programs in schools should harness the availability of student devices, such as cell phones, smart phones and PDA's.